Source:http://linkedlifedata.com/resource/pubmed/id/20118768
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2010-3-1
|
pubmed:abstractText |
We have recently shown that a study population of patients with at least 1 sessile serrated adenoma (SSA) are 4 times more likely to harbor synchronous serrated polyps [SSAs, traditional serrated adenomas (TSAs) and right sided hyperplastic polyps] than a unselected population of patients. However, 35% of the polyps in the study patients were conventional adenomas (CAds). We hypothesized that the CAds in these study patients would have histologic and molecular differences compared with CAds from a control population without sessile serrated adenomas. To this end, 104 study and 79 control CAds were analyzed according to 9 histologic criteria. A subset of these polyps was also screened for BRAF mutations, KRAS mutations, CpG island methylation, and MUC6 expression. A total of 31 study CAds and 2 control CAds had atypical histologic features (bright cytoplasmic eosinophilia +/- focal serrations and crypt dilatation). None of the adenomas tested had mutations in BRAF or KRAS. Evidence of low levels of CpG island methylation was seen in 35% of the atypical CAds and in only 4.5% of the typical CAds. In addition, these atypical CAds were more likely to express MUC6. Thus, the presence of cytoplasmic eosinophilia with or without focal serrations and crypt dilatation identifies a subset of CAds with characteristics of the serrated neoplasia pathway. These atypical CAds occur more commonly in patients predisposed to developing SSAs and suggest the presence of a mucosal field defect in these patients.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/BRAF protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/KRAS protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/MUC6 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Mucin-6,
http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins B-raf,
http://linkedlifedata.com/resource/pubmed/chemical/ras Proteins
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
1532-0979
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
34
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
355-63
|
pubmed:meshHeading |
pubmed-meshheading:20118768-Adenoma,
pubmed-meshheading:20118768-Aged,
pubmed-meshheading:20118768-Case-Control Studies,
pubmed-meshheading:20118768-Colonic Neoplasms,
pubmed-meshheading:20118768-Colonic Polyps,
pubmed-meshheading:20118768-CpG Islands,
pubmed-meshheading:20118768-DNA Methylation,
pubmed-meshheading:20118768-DNA Mutational Analysis,
pubmed-meshheading:20118768-Dilatation, Pathologic,
pubmed-meshheading:20118768-Eosinophilia,
pubmed-meshheading:20118768-Female,
pubmed-meshheading:20118768-Gene Expression Regulation, Neoplastic,
pubmed-meshheading:20118768-Humans,
pubmed-meshheading:20118768-Hyperplasia,
pubmed-meshheading:20118768-Immunohistochemistry,
pubmed-meshheading:20118768-Intestinal Mucosa,
pubmed-meshheading:20118768-Male,
pubmed-meshheading:20118768-Middle Aged,
pubmed-meshheading:20118768-Mucin-6,
pubmed-meshheading:20118768-Mutation,
pubmed-meshheading:20118768-Precancerous Conditions,
pubmed-meshheading:20118768-Proto-Oncogene Proteins,
pubmed-meshheading:20118768-Proto-Oncogene Proteins B-raf,
pubmed-meshheading:20118768-ras Proteins
|
pubmed:year |
2010
|
pubmed:articleTitle |
Identification of histologically distinct conventional adenomas that arise predominately in patients with sessile serrated adenomas.
|
pubmed:affiliation |
Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110-1093, USA. rpai@path.wustl.edu
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|